M. S. Chapman, J. Cirulli, and S. McBride, “Sustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis”, J of Skin, vol. 2, no. S1, p. S23, Feb. 2018.